VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 213 filers reported holding VERACYTE INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $578 | -12.4% | 25,872 | -0.2% | 0.03% | -6.1% |
| Q2 2023 | $660 | +6.5% | 25,915 | -6.8% | 0.03% | +17.9% |
| Q1 2023 | $620 | -5.8% | 27,792 | +0.3% | 0.03% | -12.5% |
| Q4 2022 | $658 | -99.9% | 27,713 | -0.2% | 0.03% | +45.5% |
| Q3 2022 | $462,000 | +6.7% | 27,757 | +27.6% | 0.02% | +15.8% |
| Q2 2022 | $433,000 | +13.4% | 21,758 | +56.8% | 0.02% | +26.7% |
| Q1 2022 | $382,000 | -33.2% | 13,875 | 0.0% | 0.02% | -16.7% |
| Q4 2021 | $572,000 | -16.3% | 13,875 | -5.6% | 0.02% | -18.2% |
| Q3 2021 | $683,000 | +11.8% | 14,700 | -3.7% | 0.02% | +10.0% |
| Q2 2021 | $611,000 | -25.3% | 15,267 | +0.2% | 0.02% | -31.0% |
| Q1 2021 | $818,000 | +24.5% | 15,235 | -35.2% | 0.03% | +93.3% |
| Q4 2019 | $657,000 | -52.5% | 23,500 | -59.2% | 0.02% | -51.6% |
| Q3 2019 | $1,383,000 | -16.9% | 57,600 | -1.4% | 0.03% | -18.4% |
| Q2 2019 | $1,665,000 | +13.8% | 58,400 | -0.2% | 0.04% | +26.7% |
| Q1 2019 | $1,463,000 | – | 58,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 119,680 | $2,672 | 2.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 239,571 | $5,349,620 | 1.62% |
| OBERWEIS ASSET MANAGEMENT INC/ | 597,540 | $13,343,068 | 1.42% |
| ARK Investment Management | 7,593,592 | $169,564,898 | 1.30% |
| Capital Impact Advisors, LLC | 32,969 | $736,198 | 1.23% |
| EFG Asset Management (North America) Corp. | 229,837 | $5,127,663 | 1.22% |
| Parkman Healthcare Partners LLC | 225,872 | $5,043,722 | 0.92% |
| Nikko Asset Management Americas, Inc. | 3,173,576 | $70,770,745 | 0.85% |
| Granite Investment Partners, LLC | 865,770 | $19,332,644 | 0.81% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 175,749 | $3,924,475 | 0.64% |